{
    "title": "Academics call time on $100,000 cancer drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4208846/Academics-call-time-100-000-cancer-drugs.html",
    "date": "2017-02-09",
    "keywords": [
        "cancer",
        "drug",
        "institute",
        "time",
        "gmt",
        "development",
        "oncology",
        "research",
        "pharma",
        "market",
        "price",
        "approval",
        "email",
        "ben",
        "hirschlerlondon",
        "group",
        "end",
        "year",
        "model",
        "cost",
        "concern",
        "monthskyhigh",
        "health",
        "forecasting",
        "journal",
        "cell",
        "blueprint",
        "role",
        "drugsrather",
        "consider",
        "call",
        "executive",
        "half",
        "pressure",
        "issue",
        "attack",
        "president",
        "costsa",
        "justification",
        "burden",
        "case",
        "therapiesfor",
        "example",
        "registration",
        "study",
        "medicine",
        "gene",
        "md",
        "anderson",
        "center",
        "texas",
        "solution",
        "proportion",
        "extent",
        "treatment",
        "originate",
        "labs",
        "discovery",
        "world",
        "percent",
        "focus",
        "part",
        "scale",
        "expertise",
        "money",
        "term",
        "competition",
        "biotech",
        "greg",
        "mahlich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}